FILE - This April 20, 2010, file photo shows an exterior view of Amgen offices in Fremont, Calif. Amgen Inc. agreed on Tuesday, Dec. 18, 2012, to pay $762 million to resolve federal litigation accusing the drugmaker of marketing the anemia treatment Aranesp for unapproved uses. (AP Photo/Paul Sakuma, File)
News Summary: J&J recalls faulty hip implants
Published: 11:04:26 PM, Thu 14 February 2013 UTC
DEJA VU: Johnson & Johnson again recalled thousands of its hip implants because a high percentage don't work right and have to be replaced within several years.
THE DETAILS: The recall covers 7,500 all-metal hip implants, sold under the Adept brand between 2004 and 2011 in 21 countries, but not the U.S. That's after national registries in two countries found between 7 and 12 percent of the implants failed within 3 to 5 years.
THE HISTORY: J&J has issued more than 30 product recalls since 2009, including one for two other types of hip implants, the DePuy ASR brands.
Tags:
johnson, j&j, deja vu, health, u.s., news summary, countries, history, details, hip implants, thousands, brand, product, recall election, recall, faulty hip implants, all-metal hip implants, depuy asr brands, high percentage, adept brand, national registries, 1, déjà vu, brand management
